Mode
Text Size
Log in / Sign up
N/A N=216 Randomized Single-blind Supportive Care

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment

Dementia · Mild Cognitive Impairment · Alzheimer Disease

Enrolled (actual)
216
Serious AEs
0.0%
Results posted
May 2022
Primary outcome: Primary: 3 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D) — 16.05; 18.39 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
In-Home Technology System and Questionnaires (Device); Waiting Control In-Home Technology System and Questionnaires (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, Berkeley
Primary completion
Dec 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
3 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)
16.05; 18.39
PRIMARY
6 Months Assessment for Center for Epidemiological Studies Depression Scale (CES-D)
15.98; 17.17
PRIMARY
3 Months Assessment for Zarit Burden Interview-Short Form
20.40; 21.31
PRIMARY
6 Months Assessment for Zarit Burden Interview-Short Form
20.93; 21.87
PRIMARY
3 Months Assessment for Beck Anxiety Inventory (BAI)
8.06; 9.29
PRIMARY
6 Months Assessment for Beck Anxiety Inventory (BAI)
7.81; 8.71
PRIMARY
3 Months Assessment for Satisfaction With Life Scale
21.26; 18.68
PRIMARY
6 Months Assessment for Satisfaction With Life Scale
21.28; 18.66

Summary

This study aims to develop and evaluate new in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment.

Eligibility Criteria

Inclusion Criteria

  • Caregivers are fluent/literate in English
  • Caregivers currently reside with spouse/family member who has received a diagnosis of Alzheimer's disease, other dementias, or mild cognitive impairment
  • Caregivers primarily use a smartphone (e.g., iPhone, Android)
  • Caregiver has wireless internet in home

Exclusion Criteria

  • Caregivers providing care for individuals with known non-neurodegenerative conditions affecting behavior and cognition
  • Caregivers providing care for individuals with longstanding Axis I psychiatric disorder
  • Caregivers providing care for individuals with metabolic disorder or major organ dysfunction
  • Caregivers providing care for individuals with alcohol abuse or dependence (within 5 years of dementia onset)
  • Caregivers providing care for individuals with head trauma with loss of consciousness greater than 30 minutes
  • Caregivers providing care for individuals with contraindications to MRI imaging
  • Caregivers providing care for individuals with large confluent white matter lesions
  • Caregivers providing care for individuals with significant systemic medical illness
  • Caregivers providing care for individuals who use a medication likely to affect central nervous system functions adversely
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04206670). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search